Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis. Havla J, Tackenberg B, Hellwig K, Meinl I, Krumbholz M, Seitz F, Eienbröker C, Gold R, Hohlfeld R, Kleiter I, et al. J Neurol. 2012 Dec 25. Epub 2012 Dec 25. PMID: 23266894. Abstract CommentRecommendBookmarkWatch